Researchers have uncovered what they’re calling a “cannabis paradox.” It turns out that adults who enjoy a little cannabis and then find themselves admitted to the hospital after a heart attack actually seem to fare better than their non-toking counterparts.
In a twist worthy of a plotline in a cannabis-themed thriller, a lesser-known cannabinoid called CBG has left scientists pleasantly surprised—and perhaps a little bewildered.
Marijuana use has stayed pretty chill between 2022 and 2023, according to a new federal report by the Substance Abuse and Mental Health Services Administration (SAMHSA).
CBD might soon be your skin’s new best friend in the fight against sun damage, according to some intriguing new research.
The USDA just gave the nod to a genetically modified hemp strain cooked up by researchers in Wisconsin, and boy, is it shaking things up like a leaf in the wind.
CBD, or cannabidiol, has gained popularity for its potential therapeutic benefits and its purported ability to promote overall well-being.
An ambitious project aimed at expanding Australian hemp cultivation to 100,000 hectares over the span of a decade has been abandoned after failing to secure a grant from the government’s Cooperative Research Centres (CRC) program.
Oregon State University’s Global Hemp Innovation Center has been awarded a significant $10 million grant to spearhead economic development initiatives across 13 Native American Tribes by establishing hemp processing facilities.
Recent research has shed light on the prevalence of delta 8 THC use among high school seniors, revealing that more than one in 10 students have consumed products containing this cannabinoid over the past year.
Vice President Kamala Harris is set to convene a significant discussion at the White House on drug policy reform, welcoming guests including Kentucky Governor Andy Beshear and rapper Fat Joe, both recipients of cannabis pardons from President Biden.
